Medical News Update
- Generic Drug Facilities, Sites and Organization Lists
- Drug Alerts and Statements
- What's New Related to Drugs
- International Collaboration to Advance New Testing Methods That Reduce Reliance on Horseshoe Crab Blood
- Medical Countermeasure Monitoring and Assessment
- Ana Salazar Modela Tu Cuerpo Inc. Issues Nationwide Voluntary Recall of Lipofit Extreme Fat Burner 2.0 Due to Presence of Undeclared Fluoxetine and 2,4-Dinitrophenol (DNP)
- Rare Disease Drug Approvals
- Rare Disease News & Events
- Drugs@FDA Data Files
- Notable Approvals | Drugs
- FDA Approves Treatment for Essential Thrombocythemia
- B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride Injection USP, 100 mL, in a 150 mL PAB® Container Due to the Presence of Particulate Matter
- Novel Drug Approvals for 2026
- FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
- Outsourcing Facilities | Annual Study
- FDA Approves Stelara for Pediatric Ulcerative Colitis
- Regulatory Education for Industry (REdI) Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products - 05/19/2026
- Partnership for DSCSA Governance (PDG)/FDA Joint Public Meeting: DSCSA Stabilization Period Midway Checkpoint - 06/17/2024
- Mitigating Risks from Human Xylazine Exposure - 10/04/2023
- FDA Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Select Dosages for Combination Therapies and New Indications - 11/09/2023